Accordingly, in the ideal time of MSC therapy after the establishment of the IPF models (6–90 days), TNF-α and TGF-β1 levels returned to normal levels [8, 14–16]. The gene discussed is TNF; the disease is idiopathic pulmonary fibrosis.